Printer Friendly

GE Healthcare showcases innovations in cardiology care at Arab Health 2008 MUSE cardiology information system, MAC 400 and MARS Holter system are hig.

GE Healthcare, the US$17 billion unit of General Electric Company (GE), is showcasing its innovations in cardiology care at Arab Health 2008, the premier healthcare expo held in Dubai. The highlights of GE's cardiology care solutions include the MUSE[R] cardiology information system; the MAC 400 - a unique ECG; and the MARS Holter system using GE's Marquette Algorithms. GE's MUSE[R] cardiology information system This system comes with a software platform that is poised for the future - ready to support future technology developments and the future needs of any facility dealing with cardiology data. GE Healthcare involved medical specialists worldwide to assist in the development and enhancement of the MUSE system. This led to the latest version that builds on the strengths of the previous versions to incorporate significant enhancements in information technology, ECG workflow, cardiology management processes and clinical report editing. It is easier to use with its redesigned graphical user interface and new review tools help to expedite reporting capabilities and streamline workflow. The MUSE database can be linked to the hospital intranet, enabling ECGs to be viewed anywhere in the hospital on any computer via password-secured access. The MobileLink technology enables the seamless flow of ECG data from the cardiographs to the MUSE data management system via wireless transfer. MUSE in turn has the ability to link to the Patient Administration System (PAS) enabling the matching up of patient names and ID numbers. Using GE cardiographs and MUSE gives you GE technology with the ability to eliminate the mismatch of patient names and ID numbers. MAC 400 In line with the company's 'Early Health' model that encourages faster diagnoses, GE Healthcare's MAC 400 is a unique ECG, designed to help physicians in emerging markets, whether they work in a hospital setting or in a private practice, to better predict and diagnose patients at risk of heart diseases. It is highly portable, easy-to-use and allows for various patients' configurations to assist the physician in making faster, more confident cardiac assessment and providing better patient care. The same quality and clinical excellence of the Marquette 12SL algorithm that reside in GE Healthcare's premium ECG devices is made available in the compact MAC 400 to help every physician use GE technology and perform reliable ECGs on every patient. "Measuring the electrical activity of the heart through an ECG is the very first step in diagnosing heart disease. This is why it is essential to make this procedure available to every physician, every patient, everywhere including the emerging countries. The combination of GE's legacy in clinical excellence, its trusted ECG quality and our high standards in manufacturing processes, all contribute to making the new MAC 400 the appropriate ECG solution for a physician's office," said Dr. Matthias Weber, Vice- President of GE Healthcare's Diagnostic Cardiology business. T-wave Alternans (TWA) and Heart Rate Turbulence (HRT) GE Healthcare's algorithms for the measurement of T-wave Alternans (TWA) and Heart Rate Turbulence (HRT) and their usefulness in helping to predict people at risk of sudden cardiac death, is the other highlight at Arab Health 2008. Recently, the Journal of the American College of Cardiology (December issue) included a significant study addressing their validity. The study is called REFINE abbreviated for Risk Estimation Following Infarction, Noninvasive Evaluation. Dr. Derek Exner associate professor of medicine at the University of Calgary and his colleagues evaluated 322 people who wore Holter monitors for 18 to 24 hours a day, starting two to four weeks after they had suffered a heart infarction. The researchers looked at the electrocardiograms (ECG) recorded by the devices for an abnormality in ECG called T-wave Alternans (TWA), a symptom so subtle it can be detected only by computer analysis. Moreover, the electrocardiograms were also analyzed for the presence of Heart Rate Turbulence (HRT), an abnormality of the autonomic nervous system that controls heart function. The research team found that the presence of the two abnormalities clearly identified persons at increased risk; the study participants who had both abnormalities had more than six times the risk of cardiac arrest or death than other people in the study. "In our study the combination of Holter-based Heart Rate Turbulence and T-wave Alternans strongly predicted the later development of serious outcomes after a myocardial infarction," said Dr. Exner. This study is of particular importance because with a simple method it identifies approximately twice as many people at risk comparing to past studies, focusing on a single test. That means clinicians can potentially save more lives. These Holter-based measurements are currently available in the Middle East exclusively through the use of GE Healthcare's MARS Holter system using GE's Marquette Algorithms for HRT and TWA. "With offering both TWA and HRT in our MARS Holter product, GE Healthcare is uniquely positioned to provide physicians with the most comprehensive suite of measurements to help them predict people at risk of Sudden Cardiac Death," said Dr. Weber. "This portfolio of predictive measurements strengthens a physician's ability to prescribe a treatment earlier and potentially save a patient's life." -ends- Note to Editors About GE Healthcare: GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest. GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a US$17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries.

[c] 2008 Al Bawaba (www.albawaba.com)
COPYRIGHT 2008 Al Bawaba (Middle East) Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Albawaba.com
Date:Jan 31, 2008
Words:1004
Previous Article:Amal Hijazi's "How's the Moon".
Next Article:Emirates Shipping Line joins North China India Express.
Topics:


Related Articles
Healthcare Information Systems Hotlist.
The show of shows: HIMMS 2004 offers the industry's best mix of healthcare IT solutions.
GE HEALTHCARE UNVEILS NEW CARDIOVASCULAR IMAGING SYSTEM.
Hospital information systems HotList.
Arab Health 2009 already a virtual sell out.
Arab Health Achievement Awards Announced for 2008.
SIEMENS HEALTHCARE DEBUTS CARDIOVASCULR SOLUTIONS.
GE Healthcare to focus on emerging healthcare trends at second annual Middle East Media Summit.
GE Healthcare to focus on emerging healthcare trends at second annual Middle East Media Summit.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters